Message 2: The Effect of Message Content & Clinical Outcome on Patient's

Status Completed

Clinical Trial Summary

The goal of this research study is to learn how patients view their doctor's compassion about supportive care and treatment options for advanced cancer patients.

Clinical Trial Description

If you agree to take part in this study, during an already scheduled office visit, you will complete the following:

- Basic information about you will be collected from your medical record (such as your date of birth, date of diagnosis, sex, and religion).

- You will complete 4 questionnaires about any symptoms you may be having, how hopeful you are in general, how you are dealing with the disease, your trust in the medical profession, and your strength of religious faith. It should take about 10 minutes total to complete all questionnaires.

You will then be randomly assigned (as in the flip of a coin) to 1 of 2 groups. Each group will watch a short video that shows actors playing a doctor and patient having a conversation about different cancer treatment options. Each video is about 4 minutes long and will discuss the same material, but the message shown in the videos will be different for each group.

After you watch the video, you will complete 3 questionnaires that will ask about your impression of the doctor in the video, how hopeful you think the doctor was, if you think the doctor was professional, and how you would rate the doctor overall. It should take about 8 minutes total to complete all questionnaires.

You will then read a small story about the patient in the video. Afterwards, you will complete the same 3 questionnaires that you filled out after you watched the video. You will also complete an additional questionnaire about your impression of the doctor's compassion and trustworthiness. This should take less than 10 minutes to complete.

Length of Study:

It should take about 25 minutes total to watch the video and to complete all questionnaires. Your active participation on this study will be over after you have completed the last questionnaire.

Other Information:

You are taking part in this study alone. Your family members will not be in the room with you. If you request, your family may be able remain in the room, but the investigators ask that they remain silent.

This is an investigational study.

Up to 128 participants will be enrolled in this study. All will take part at MD Anderson. ;

Study Design

Related Conditions & MeSH terms

Advanced Cancers

Clinical Trial Details

NCT number	NCT02498899
Study type	Interventional
Source	M.D. Anderson Cancer Center
Contact
Status	Completed
Phase	N/A
Start date	July 2015
Completion date	December 6, 2018

View Details

See also
Status	Clinical Trial	Phase
Completed	`NCT01213238` - Hepatic Arterial Infusion Oxaliplatin, Capecitabine With or Without Bevacizumab	Phase 1
Recruiting	`NCT02160366` - Profile Related Evidence to Determine Individualized Cancer Therapy (PREDICT) Program in Advanced Cancer Patients
Completed	`NCT00379353` - The Effects of Thalidomide on Symptom Clusters	Phase 2
Completed	`NCT00903708` - LY2275796 in Advanced Cancer	Phase 1
Terminated	`NCT00499382` - Quantitation of Left Ventricular Ejection Fraction as Part of F-18 FDG Whole Body PET/CT Scans For Tumor Staging	N/A
Completed	`NCT02459964` - Compare Fentanyl Nasal Spray With Intravenous Opioids to Treat Severe Pain	Phase 4
Completed	`NCT01430572` - Pazopanib and Everolimus in PI3KCA Mutation Positive/PTEN Loss Patients	Phase 1
Completed	`NCT02561234` - A Multiple Dose, Dose Escalation Trial of AEB1102 in Patients With Advanced Solid Tumors	Phase 1/Phase 2
Active, not recruiting	`NCT01375114` - The Effects of Ginseng on Cancer-Related Fatigue	Phase 2
Completed	`NCT01201694` - Phase I Study of Surface-Controlled Water Soluble Curcumin (THERACURMIN CR-011L)	Phase 1
Completed	`NCT01454804` - Pazopanib, Lapatinib or Trastuzumab in Subjects With Solid Tumors	Phase 1
Completed	`NCT02801045` - Art Therapy in Palliative Care: Study of Identification and Understanding of the Mechanisms of Change in the Patient	N/A
Completed	`NCT02873975` - A Study of LY2606368 (Prexasertib) in Patients With Solid Tumors With Replicative Stress or Homologous Repair Deficiency	Phase 2
Completed	`NCT01983969` - Aza-SAHA-GBM With AutoSCT for Refractory Lymphoma	Phase 1/Phase 2
Completed	`NCT02272595` - Rational Therapeutics Based on Matched Tumor and Normal Tissue
Active, not recruiting	`NCT01999491` - A Phase 1 Dose-Escalation and Pharmacokinetic Study of NC-4016 in Patients With Advanced Solid Tumors or Lymphoma	Phase 1
Recruiting	`NCT03375983` - Plasmodium Immunotherapy for Advanced Cancers	Phase 1/Phase 2
Completed	`NCT02571036` - A Safety, Tolerability and PK Study of DCC-2618 in Patients With Advanced Malignancies	Phase 1
Withdrawn	`NCT01608139` - Study of Curcumin, Vorinostat, and Sorafenib	Phase 1
Completed	`NCT01024166` - Patient-Reported Outcomes-Based Palliative and Hospice Care Practice: A Usability Study	N/A

Clinical trials are conducted in a series of steps, called phases - each phase is designed to answer a separate research question.

Phase 1: Researchers test a new drug or treatment in a small group of people for the first time to evaluate its safety, determine a safe dosage range, and identify side effects.
Phase 2: The drug or treatment is given to a larger group of people to see if it is effective and to further evaluate its safety.
Phase 3: The drug or treatment is given to large groups of people to confirm its effectiveness, monitor side effects, compare it to commonly used treatments, and collect information that will allow the drug or treatment to be used safely.
Phase 4: Studies are done after the drug or treatment has been marketed to gather information on the drug's effect in various populations and any side effects associated with long-term use.

Message 2: The Effect of Message Content and Clinical Outcome on Patient's Perception of Physician Compassion

Clinical Trial Summary

Clinical Trial Description

Study Design

Related Conditions & MeSH terms